Non-alcoholic fatty liver disease (NAFLD), a metabolic syndrome (MetS) manifested in the liver (Buzzetti, Pinzani & Tsochatzis, 2016), is pathophysiologically related to adipose tissue inflammation and insulin resistance (Tilg, Adolph & Moschen, 2021). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.